Qiagen NV | QIA - Interest Expense On Debt


Qiagen NV reported $10.02M in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
Akebia Therapeutics 342.13M 7.53M Sep/2026
Alaunos Therapeutics USD 1.07M 215K Jun/2023
argenx SE USD 1000K 0 Sep/2026
Avita Medical AUD 1.25M 100K Jun/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 4M 14M Sep/2026
IQVIA Holdings USD 203M 6M Sep/2026
Moderna USD 10.96B 527M Jun/2026
Organon & Co USD 106M 2M Sep/2026
Qiagen NV USD 10.02M 1.03M Jun/2026
Revvity USD 20.81M 2.18M Sep/2026
Tectonic Therapeutic USD 237.03M 9.54M Jun/2026
Viatris USD 112.4M 8.3M Sep/2026
Xeris Pharmaceuticals USD 6.95M 63K Jun/2026